ArticleFrontiers in neurology2022

Case report: Monoclonal CGRP-antibody treatment in a migraine patient with a mutation in the mitochondrial single-strand binding protein (SSBP1).

Katharina Kaltseis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.